COVISUS LLC COMPLETES SUCCESSFUL PILOT TESTING OF QUANTEK 5900 WITH HONEYWELL
Covisus LLC, a leader in tag-less anti-counterfeiting solutions, has successfully completed pilot testing of QuanTEK 5900 with Honeywell. The QuanTEK 5900 met predetermined expectations and is now available for commercial use. The QuanTEK platform uses innovative optical imaging technology to extract a unique digital fingerprint from the surface of a part in a non-contact manner. This digital fingerprint, also called a virtual intrinsic tag or vTAGTM is stored in a secure cloud database. Every time a part changes custody, a new vTAGTM is generated and compared with the stored vTAGTM and if a match is found, the part is declared as secure. If a match is not found, the part is declared as suspect. This methodology also provides traceability as the part moves through the supply chain. The QuanTEK 5900 system was designed for Electronic Integrated Circuits or Federal Supply Class 5962. The pilot testing was conducted by Honeywell personnel in their Clearwater Florida facility over a period of two weeks. Testing was conducted using plastic, metal, ceramic, and hybrid metal-ceramic integrated circuits of different dimensions and package styles. The test use cases were formulated through joint discussions to emulate real field conditions. In addition to functional testing, system tests were carried out to check the Graphical User Interface, reporting functions, and system speed. Tests were also conducted on blacktopped parts to check whether QuanTEK could identify and screen them out. Naresh Menon, founder and CEO of Covisus stated, “In field enrollment and verification of parts and their traceability is very important to our customers. QuanTEK’s unique tag-less nature and easy to use GUI and reporting functions, allows our customers to rapidly check for counterfeit parts on-site and provides them the needed assurance of supply chain integrity. We are grateful that Honeywell invested their time in pilot testing QuanTEK and are very pleased with the results.” For more information about QuanTEK, please contact Covisus at www.covisus.com.